Implications and limitations of cellular reprogramming for psychiatric drug development
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Human-induced pluripotent stem cells (hiPSCs) derived from somatic cells of patients have opened possibilities for in vitro modeling of the physiology of neural (and other) cells in psychiatric disease states. Issues in early stages of technology development include (1) establishing a library of cells from adequately phenotyped patients, (2) streamlining laborious, costly hiPSC derivation and characterization, (3) assessing whether mutations or other alterations introduced by reprogramming confound interpretation, (4) developing efficient differentiation strategies to relevant cell types, (5) identifying discernible cellular phenotypes meaningful for cyclic, stress induced or relapsing–remitting diseases, (6) converting phenotypes to screening assays suitable for genome-wide mechanistic studies or large collection compound testing and (7) controlling for variability in relation to disease specificity amidst low sample numbers. Coordination of material for reprogramming from patients well-characterized clinically, genetically and with neuroimaging are beginning, and initial studies have begun to identify cellular phenotypes. Finally, several psychiatric drugs have been found to alter reprogramming efficiency in vitro, suggesting further complexity in applying hiPSCs to psychiatric diseases or that some drugs influence neural differentiation moreso than generally recognized. Despite these challenges, studies utilizing hiPSCs may eventually serve to fill essential niches in the translational pipeline for the discovery of new therapeutics. Stem cell-derived neurons could accelerate discovery of psychiatric drugs and help clinicians to provide optimal treatment for their patients. Individuals with mental illness have limited therapeutic options, and many endure months of unsuccessful treatment before finding an effective drug. A review from Evan Snyder and colleagues at the Sanford-Burnham Medical Research Institute, USA, explored the potential of human induced pluripotent stem cells (hiPSCs) as a tool for providing patients with better options. Closely resembling embryonic stem cells, hiPSCs are derived by reprogramming cells from mature tissue. This means a skin biopsy can be transformed into patient-specific neural tissue, which could be used to determine a given drug's mechanism of action with respect to that particular patient's disease state. With additional insights into the cellular basis of psychiatric disease, hiPSC-derived neurons could also assist in finding new drugs that repair specific cellular abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“differences in an individual's methylation status and biological age sees that cellular reprogramming will never be a one size fits all, as rewinding cells too far back could have dire consequence for specific tissues. 53 , 54 , 55”
From Three Tiers to biological escape velocity: The quest to outwit aging (2022) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329
Somatic coding mutations in human induced pluripotent stem cells
Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273
Structural Variation in the Human Genome and its Role in Disease
Stankiewicz, P., & Lupski, J. R. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-100708-204735 · Cited by 1,201
The antidepressant fluoxetine restores plasticity in the adult visual cortex
Vetencourt, J. F. M., Sale, A., Viegi, A., Baroncelli, L., De Pasquale, R., F. O'Leary, O., Castrén, E., & Maffei, L. (2008) · Science · doi:10.1126/science.1150516 · Cited by 890
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667
Research works printed but not linked: 84
- Carpenter WT, Koenig JI . The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology 2008; 33: 2061–2079. · DOI · Paper page
- Barnes TR, Paton C . Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs 2011; 25: 383–399. · DOI · Paper page
- Zink M, Englisch S, Meyer-Lindenberg A . Polypharmacy in schizophrenia. Curr Opin Psychiatry 2010; 23: 103–111. · DOI · Paper page
- Becker RE, Greig NH . Lost in translation: neuropsychiatric drug development. Sci Transl Med 2010; 2: 61rv6. · DOI
- Cowen PJ . Serotonin and depression: pathophysiological mechanism or marketing myth? Trends Pharmacol Sci 2008; 29: 433–436. · DOI · Paper page
- Mostert JP, Koch MW, Heerings M, Heersema DJ, De Keyser J . Therapeutic potential of fluoxetine in neurological disorders. CNS Neurosci Ther 2008; 14: 153–164. · DOI
- Krishnan A, Hariharan R, Nair SA, Pillai MR . Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem Pharmacol 2008; 75: 1924–1934. · DOI
- Beaulieu JM, Caron MG . Looking at lithium: molecular moods and complex behaviour. Mol Interv 2008; 8: 230–241. · DOI · Paper page
- Pardo R, Andreolotti AG, Ramos B, Picatoste F, Claro E . Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms. J Neurochem 2003; 87: 417–426. · DOI · Paper page
- Catapano LA, Manji HK . Kinases as drug targets in the treatment of bipolar disorder. Drug Discov Today 2008; 13: 295–302. · DOI
- Tardito D, Tiraboschi E, Kasahara J, Racagni G, Popoli M . Reduced CREB phosphorylation after chronic lithium treatment is associated with down-regulation of CaM kinase IV in rat hippocampus. Int J Neuropsychopharmacol 2007; 10: 491–496. · DOI · Paper page
- Hahn CG, Friedman E . Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 1999; 1: 81–86. · DOI · Paper page
- Quiroz JA, Machado-Vieira R, Zarate CA Jr, Manji HK . Novel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 2010; 62: 50–60. · DOI · Paper page
- McCarthy MJ, Leckband SG, Kelsoe JR . Pharmacogenetics of lithium response in bipolar disorder. Pharmacogenomics 2010; 11: 1439–1465. · DOI · Paper page
- Camins A, Crespo-Biel N, Junyent F, Verdaguer E, Canudas AM, Pallas M . Calpains as a target for therapy of neurodegenerative diseases: putative role of lithium. Curr Drug Metab 2009; 10: 433–447. · DOI · Paper page
- Perlis RH, Smoller JW, Ferreira MA, McQuillin A, Bass N, Lawrence J et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 2009; 166: 718–725. · DOI · Paper page
- Antonelli A, Ferrari SM, Fallahi P, Berti P, Materazzi G, Barani L et al. Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests. Clin Endocrinol (Oxf) 2008; 69: 148–152. · DOI · Paper page
- Bagriacik EU, Baykaner MK, Yaman M, Sivrikaya G, Durdag E, Emmez H et al. Establishment of a primary pleomorphic xanthoastrocytoma cell line: in vitro responsiveness to some chemotherapeutics. Neurosurgery 2011; 70: 188–197. · doi:10.1227/neu.0b013e3182262c5b
- Basu D, Montone KT, Wang LP, Gimotty PA, Hammond R, Diehl JA et al. Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas. Cell Cycle 2011; 10: 2008–2016. · DOI
- Suzuki M, Ishikawa H, Tanaka A, Mataga I . Heterogeneity of anticancer drug sensitivity in squamous cell carcinoma of the tongue. Hum Cell 2011; 24: 21–29. · doi:10.1007/s13577-010-0004-x
- Liu R, Hsieh CY, Lam KS . New approaches in identifying drugs to inactivate oncogene products. Semin Cancer Biol 2004; 14: 13–21. · doi:10.1016/j.semcancer.2003.11.003
- Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145–1147. · DOI · Paper page
- Cai J, Li W, Su H, Qin D, Yang J, Zhu F et al. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 2010; 285: 11227–11234. · DOI · Paper page
- Kaneko S, Otsu M, Nakauchi H . Reprogramming adult hematopoietic cells. Curr Opin Hematol 2010; 17: 271–275. · DOI
- Kim JB, Greber B, Arauzo-Bravo MJ, Meyer J, Park KI, Zaehres H et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009; 461: 649–3. · DOI · Paper page
- Unternaehrer JJ, Daley GQ . Induced pluripotent stem cells for modelling human diseases. Philos Trans R Soc Lond Ser B 2011; 366: 2274–2285. · DOI · Paper page
- Takahashi K, Okita K, Nakagawa M, Yamanaka S . Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007; 2: 3081–3089. · DOI · Paper page
- Chiang CH, Su Y, Wen Z, Yoritomo N, Ross CA, Margolis RL et al. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry 2011; 16: 358–360. · DOI · Paper page
- Sidhu KS . New approaches for the generation of induced pluripotent stem cells. Expert Opin Biol Ther 2011; 11: 569–579. · DOI
- Muller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP et al. A bioinformatic assay for pluripotency in human cells. Nat Methods 2011; 8: 315–317. · DOI · Paper page
- Howden SE, Gore A, Li Z, Fung HL, Nisler BS, Nie J et al. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci USA 2011; 108: 6537–6542. · DOI
- Robicsek O, Karry R, Petit I, Salman-Kesner N, Muller FJ, Klein E et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry 2013; 18: 1067–1076. · DOI · Paper page
- Yeo GW, Coufal N, Aigner S, Winner B, Scolnick JA, Marchetto MC et al. Multiple layers of molecular controls modulate self-renewal and neuronal lineage specification of embryonic stem cells. Hum Mol Genet 2008; 17: R67–R75. · DOI
- Dhara SK, Stice SL . Neural differentiation of human embryonic stem cells. J Cell Biochem 2008; 105: 633–640. · DOI · Paper page
- Li W, Sun W, Zhang Y, Wei W, Ambasudhan R, Xia P et al. Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. Proc Natl Acad Sci USA 2011; 108: 8299–8304. · DOI · Paper page
- Lee G, Chambers SM, Tomishima MJ, Studer L . Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc 2010; 5: 688–701. · DOI · Paper page
- Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L . Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009; 27: 275–280. · DOI · Paper page
- Nguyen HN, Byers B, Cord B, Shcheglovitov A, Byrne J, Gujar P et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011; 8: 267–280. · DOI · Paper page
- Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA 2010; 107: 15921–15926. · DOI · Paper page
- Emdad L, D'Souza SL, Kothari HP, Qadeer ZA, Germano IM . Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev 2012; 21: 404–410. · DOI
- Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471: 58–62. · DOI · Paper page
- Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7: 521–531. · DOI · Paper page
- Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, Wainger BJ et al. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 2011; 29: 279–286. · DOI · Paper page
- Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010; 107: 4335–4340. · DOI · Paper page
- Kim JE, O’Sullivan ML, Sanchez CA, Hwang M, Israel MA, Brennand K et al. Investigating synapse formation and function using human pluripotent stem cell-derived neurons. Proc Natl Acad Sci USA 2011; 108: 3005–3010. · DOI · Paper page
- Caiazzo M, Dell'anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011; 476: 224–227. · DOI · Paper page
- Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M . Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463: 1035–1041. · DOI · Paper page
- Kim J, Efe JA, Zhu S, Talantova M, Yuan X, Wang S et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci USA 2011; 108: 7838–7843. · DOI · Paper page
- Kim KS, Lee HJ, Jeong HS, Li J, Teng YD, Sidman RL et al. Self-renewal induced efficiently, safely, and effective therapeutically with one regulatable gene in a human somatic progenitor cell. Proc Natl Acad Sci USA 2011; 108: 4876–4881. · doi:10.1073/pnas.1019743108
- Zhao T, Zhang ZN, Rong Z, Xu Y . Immunogenicity of induced pluripotent stem cells. Nature 2011; 474: 212–215. · DOI · Paper page
- Nestler EJ, Hyman SE . Animal models of neuropsychiatric disorders. Nat Neurosci 2010; 13: 1161–1169. · DOI · Paper page
- Ryder PV, Faundez V . Schizophrenia: the ‘BLOC’ may be in the endosomes. Sci Signal 2009; 2: pe66. · DOI
- Henning U, Krieger K, Loeffler S, Rivas F, Orozco G, de Castro MG et al. Increased levels of glucocorticoid receptors and enhanced glucocorticoid receptor auto-regulation after hydrocortisone challenge in B-lymphoblastoids from patients with affective disorders. Psychoneuroendocrinology 2005; 30: 325–332. · DOI
- D'Aiuto L, Di Maio R, Heath B, Raimondi G, Milosevic J, Watson AM et al. Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells. PLoS One 2012; 7: e49700. · DOI
- Basta-Kaim A, Budziszewska B, Jaworska-Feil L, Tetich M, Kubera M, Leskiewicz M et al. Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases. Neuropsychopharmacology 2006; 31: 853–865. · DOI
- Kurosawa S, Hashimoto E, Ukai W, Toki S, Saito S, Saito T . Olanzapine potentiates neuronal survival and neural stem cell differentiation: regulation of endoplasmic reticulum stress response proteins. J Neural Transm 2007; 114: 1121–1128. · DOI
- Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM . Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience 2003; 117: 55–61. · DOI
- Laeng P, Pitts RL, Lemire AL, Drabik CE, Weiner A, Tang H et al. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 2004; 91: 238–251. · DOI · Paper page
- Hisaoka K, Maeda N, Tsuchioka M, Takebayashi M . Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production. Brain Res 2008; 1196: 53–58. · DOI
- Zhou X, Barrett TB, Kelsoe JR . Promoter variant in the GRK3 gene associated with bipolar disorder alters gene expression. Biol Psychiatry 2008; 64: 104–110. · DOI
- Huang W, Li MD . Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry 2009; 65: 702–705. · DOI
- McCarthy MJ, Wei H, Marnoy Z, Darvish R, McPhie D, Cohen B et al. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Translational Psychiatry 2013 (in press). · DOI · Paper page
- Yoshikawa A, Shimada H, Numazawa K, Sasaki T, Ikeda M, Kawashima M et al. Establishment of human cell lines showing circadian rhythms of bioluminescence. Neurosci Lett 2008; 446: 40–44. · DOI
- Kowalska E, Moriggi E, Bauer C, Dibner C, Brown SA . The circadian clock starts ticking at a developmentally early stage. J Biol Rhythms 2010; 25: 442–449. · DOI
- Kiselyuk A, Farber-Katz S, Cohen T, Lee SH, Geron I, Azimi B et al. Phenothiazine neuroleptics signal to the human insulin promoter as revealed by a novel high-throughput screen. J Biomol Screen 2010; 15: 663–670. · DOI
- Kiris E, Nuss JE, Burnett JC, Kota KP, Koh DC, Wanner LM et al. Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Res 2011; 6: 195–205. · doi:10.1016/j.scr.2011.01.002
- Lynch WP, Sharpe AH, Snyder EY . Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration. J Virol 1999; 73: 6841–6851. · DOI
- Lynch WP, Snyder EY, Qualtiere L, Portis JL, Sharpe AH . Late virus replication events in microglia are required for neurovirulent retrovirus-induced spongiform neurodegeneration: evidence from neural progenitor-derived chimeric mouse brains. J Virol 1996; 70: 8896–8907. · doi:10.1128/jvi.70.12.8896-8907.1996
- Tobe BT, Snyder EY, Nye JS . Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells. Curr Opin Pharmacol 2011; 11: 521–527. · DOI
- Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008; 26: 1269–1275. · DOI · Paper page
- Lyssiotis CA, Foreman RK, Staerk J, Garcia M, Mathur D, Markoulaki S et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci USA 2009; 106: 8912–8917. · DOI · Paper page
- Wang Q, Xu X, Li J, Liu J, Gu H, Zhang R et al. Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells. Cell Res 2011; 21: 1424–1435. · DOI · Paper page
- Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 2009; 27: 353–360. · DOI · Paper page
- Yamanaka S . Elite and stochastic models for induced pluripotent stem cell generation. Nature 2009; 460: 49–52. · DOI · Paper page
- Plath K, Lowry WE . Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet 2011; 12: 253–265. · DOI · Paper page
- Pidsley R, Mill J . Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry 2011; 69: 146–156. · DOI
- Lee MG, Wynder C, Schmidt DM, McCafferty DG, Shiekhattar R . Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 2006; 13: 563–567. · DOI · Paper page
- Yang M, Culhane JC, Szewczuk LM, Jalili P, Ball HL, Machius M et al. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Biochemistry 2007; 46: 8058–8065. · DOI · Paper page
- Karytinos A, Forneris F, Profumo A, Ciossani G, Battaglioli E, Binda C et al. A novel mammalian flavin-dependent histone demethylase. J Biol Chem 2009; 284: 17775–17782. · DOI · Paper page
- Li W, Zhou H, Abujarour R, Zhu S, Young Joo J, Lin T et al. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 2009; 27: 2992–3000. · DOI · Paper page
- Perisic T, Zimmermann N, Kirmeier T, Asmus M, Tuorto F, Uhr M et al. Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology 2010; 35: 792–805. · DOI
- Yu IT, Park JY, Kim SH, Lee JS, Kim YS, Son H . Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 2009; 56: 473–480. · DOI · Paper page
- Hester ME, Song S, Miranda CJ, Eagle A, Schwartz PH, Kaspar BK . Two factor reprogramming of human neural stem cells into pluripotency. PLoS One 2009; 4: e7044. · DOI · Paper page
- Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011; 8: 409–412. · DOI · Paper page
Cited by
The genetics of bipolar disorder
Gordovez, F. J. A., & McMahon, F. J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0634-7 · Cited by 262
Three Tiers to biological escape velocity: The quest to outwit aging
Palmer, R. D. (2022) · AGING MEDICINE · doi:10.1002/agm2.12231 · Cited by 2
Metadata
- Authors
- Tobe, B. T. D., Brandel, M. G., Nye, J. S., & Snyder, E. Y.
- Venue
- Experimental & Molecular Medicine
- Published
- 2013-11-15
- Volume
- 45
- Issue
- 11
- Pages
- e59-e59
- ISSN
- 2092-6413
- PMC
- PMC3849573
- Cited by
- 9
- References
- 16
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implications and limitations of cellular reprogramming for psychiatric drug development. https://app.cochat.ai/papers/10.1038/emm.2013.124
- The paper
- Tobe, B. T. D., Brandel, M. G., Nye, J. S., & Snyder, E. Y. (2013). Implications and limitations of cellular reprogramming for psychiatric drug development. Experimental & Molecular Medicine. https://doi.org/10.1038/emm.2013.124
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.